Peritoneal Dialysis Market Size, Share & Trends Analysis Report By Product (Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and Others), By Applications (Machine, Supplies), By End Use, By Region, and Segment Forecasts - 2035

Peritoneal Dialysis Market Overview

The global peritoneal dialysis market size was valued at USD 140.95 million in 2025 and is projected to grow from USD 149.55 million in 2026 to USD 178.61 million by 2035, at a CAGR of 6.1% from 2026 to 2035.

The Peritoneal Dialysis Market in 2026 is being shaped by growing preference for home-based kidney replacement therapy, rising end-stage kidney disease prevalence, increasing use of automated peritoneal dialysis, and wider adoption of remote patient monitoring. Around 4.5 million people worldwide received dialysis treatment in 2025, and approximately 11% of dialysis patients were treated with peritoneal dialysis, establishing a substantial addressable patient base for machines, solutions, catheter-related products, and consumables. Peritoneal Dialysis Solution is estimated to account for approximately 61% of Product Type demand because every treatment requires recurring sterile dialysate, while Peritoneal Dialysis Machine contributes approximately 27% and Others account for around 12%. By Application, Supplies are estimated to represent approximately 69% of demand, compared with about 31% for Machine, reflecting the recurring nature of fluid bags, transfer systems, connectors, tubing, and other treatment consumables. Automated systems increasingly incorporate cloud-based monitoring, remote prescription adjustment, treatment-data transmission, and supply-ordering workflows. These capabilities are making home dialysis more manageable for both patients and clinicians while supporting a shift from equipment-only competition toward integrated hardware, software, consumables, and clinical-support ecosystems.

The United States remains one of the most developed Peritoneal Dialysis Markets because home dialysis has stronger penetration than the global average and is supported by reimbursement, nephrology networks, remote monitoring, and established supply-delivery infrastructure. Approximately 15% of U.S. dialysis patients received home dialysis in 2025 compared with around 11% worldwide, giving suppliers a comparatively large home-treatment base. Supplies are estimated to represent approximately 67% of U.S. Application demand, while Machine accounts for around 33%. Peritoneal Dialysis Solution contributes approximately 58% of Product Type demand, Peritoneal Dialysis Machine represents around 30%, and Others account for approximately 12%. Connected automated peritoneal dialysis systems are becoming increasingly important; during 2025, one major digital home-dialysis ecosystem transmitted data from more than 7.7 million patient treatments and delivered approximately 58,000 therapy prescription programs remotely. These volumes demonstrate how digital connectivity is transforming patient management from periodic manual reporting toward continuous or near-continuous clinical visibility.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Peritoneal Dialysis Solution is estimated to hold approximately 61% market share because each treatment requires recurring sterile dialysate volumes, creating substantially higher repeat consumption than durable equipment.
• Leading Application: Supplies are estimated to account for approximately 69% of demand, supported by recurring use of dialysate bags, tubing, connectors, transfer systems, catheter accessories, and disposable treatment components.
• Leading Region: North America is estimated to hold approximately 36% market share, supported by established home-dialysis reimbursement, extensive nephrology networks, connected cyclers, and home treatment penetration near 15% in the U.S.
• Fastest Growing Region: Asia-Pacific is projected to expand at approximately 8.2% annually as China, India, and Southeast Asia increase dialysis access, domestic manufacturing, and home-based renal treatment capacity.
• Technology Trend: Connected therapy platforms processed data from more than 7.7 million home treatments in 2025, demonstrating rapid adoption of remote monitoring and digitally managed prescriptions.
• Market Driver: Approximately 4.5 million people received dialysis worldwide in 2025, creating a growing patient pool for peritoneal dialysis machines, solutions, accessories, and home-treatment services.
• Competitive Landscape: Leading suppliers are integrating equipment and software, with remote platforms delivering approximately 58,000 therapy prescription programs during 2025 while expanding connected home-dialysis workflows.
• Future Outlook: Peritoneal dialysis currently represents approximately 11% of global dialysis treatment, leaving substantial headroom for home-based therapy expansion as healthcare systems seek decentralized care models.

Latest Trends

Remote patient monitoring is one of the most important trends reshaping the Peritoneal Dialysis Market in 2026. Automated peritoneal dialysis machines increasingly transmit treatment data from a patient's home to clinical teams, allowing professionals to review adherence, ultrafiltration, treatment completion, alarms, and other therapy parameters without requiring every adjustment to occur during an in-person visit. In 2025, more than 7.7 million patient treatments were digitally transmitted through one major connected home-dialysis ecosystem, while approximately 58,000 prescription programs were sent remotely. The technology is evolving further in 2026 through unified platforms that combine automated peritoneal dialysis and other home-dialysis workflows within a single digital environment. Connected systems can support at least 3 major functions: remote treatment monitoring, remote prescription management, and integrated supply ordering. This reduces dependence on manual records and gives care teams more timely visibility into treatment patterns. The shift is important because peritoneal dialysis patients commonly perform therapy every day, generating substantially more treatment data than patients attending dialysis centers only several times per week.

A second major trend is expansion of home-based treatment models as healthcare systems seek to increase patient autonomy and reduce dependence on fixed dialysis infrastructure. Around 53,000 dialysis centers operated worldwide in 2025, treating an average of approximately 80 patients per facility, yet approximately 11% of dialysis patients globally were already receiving peritoneal dialysis outside conventional in-center models. Peritoneal dialysis availability nevertheless varies sharply between countries, demonstrating significant room for expansion. Manufacturers are responding through lighter cyclers, simplified disposable sets, improved connectors, mobile automated systems, and digital education tools. Newer technology aims to make therapy easier to learn while reducing the number of manual steps required for setup and documentation. Home-based treatment is especially important in regions where patients must travel more than 50 kilometers to reach specialist renal facilities, making decentralized therapy economically and clinically attractive when appropriate training and supply systems are available.

Market Dynamics

Driver

""Growing kidney failure prevalence is increasing demand for flexible home-based dialysis.""

The principal driver of the Peritoneal Dialysis Market is the increasing number of patients requiring kidney replacement therapy. Approximately 5.5 million people globally were living with kidney failure requiring dialysis or a transplant in 2025, including roughly 4.5 million dialysis patients. The global dialysis population increased by approximately 4-5% during 2025, creating persistent pressure on treatment infrastructure. Peritoneal dialysis offers an alternative to conventional facility-based hemodialysis by allowing appropriately selected patients to receive therapy at home. Approximately 11% of dialysis patients worldwide currently use peritoneal dialysis, meaning even a modest 2 percentage-point increase in penetration would translate into a substantial number of additional patients requiring machines, solutions, tubing, connectors, and other supplies.

Peritoneal dialysis also supports healthcare systems seeking to reduce facility congestion. A conventional dialysis center may treat approximately 80 patients, and many hemodialysis patients attend treatment around 3 times each week. A patient shifting to peritoneal dialysis can reduce dependence on a physical treatment chair while transferring a significant portion of routine therapy to the home. This creates demand for recurring Supplies and remote clinical support rather than only facility equipment. Supplies already account for approximately 69% of Application demand because each patient may use several liters of sterile solution daily together with disposable treatment sets. Population aging, diabetes, hypertension, and chronic kidney disease therefore provide a structural demand base extending through 2035.

Restraint

""Training requirements and infection risks can limit wider adoption of home therapy.""

The main restraint is that peritoneal dialysis requires patients or caregivers to manage a complex therapy environment at home. Training can involve multiple days covering sterile technique, catheter care, fluid exchanges, cycler operation, troubleshooting, and recognition of potential complications. A typical automated therapy may run for approximately 8-10 hours overnight and involve several exchange cycles. Patients must prepare the treatment environment correctly, connect disposable systems, monitor equipment alarms, and protect catheter access from contamination. These requirements mean peritoneal dialysis is not appropriate for every patient, particularly where physical, cognitive, social, or housing limitations affect treatment reliability.

Peritonitis remains another important restraint because contamination during connection or catheter handling can lead to serious infection. Even if infection rates are reduced to fewer than 1 episode per patient-year within well-managed programs, the clinical impact can be significant and may lead to hospitalization or transition to hemodialysis. Manufacturers therefore invest heavily in connectors, closed systems, antimicrobial strategies, training tools, and simplified workflows. Storage space also matters because patients may receive dozens of fluid bags each month. A daily therapy using approximately 8-12 liters of dialysate can require hundreds of liters of packaged solution over a month, creating logistical challenges for smaller homes.

Opportunity

""Digital home-dialysis platforms create opportunities to improve adherence and clinical efficiency.""

The strongest opportunity lies in connected automated peritoneal dialysis. Remote monitoring enables clinical teams to receive treatment information without asking patients to manually record every session. In a recent controlled evaluation involving more than 800 automated peritoneal dialysis patients across 21 hospitals, connected monitoring was studied against conventional treatment management, demonstrating the growing clinical interest in digital oversight. Modern platforms can aggregate thousands of data points across nightly therapies, helping providers identify incomplete sessions, fluid-management concerns, or recurring alarms earlier. For suppliers, digital connectivity extends competition beyond machines and disposable sets into software, analytics, workflow integration, and long-term service relationships.

Emerging economies provide another major opportunity because peritoneal dialysis access remains uneven. In some high-income markets, home dialysis is available to a substantial share of patients, while lower-resource regions may have very limited access. Peritoneal dialysis can be particularly attractive in areas without dense dialysis-center networks because it requires less fixed facility infrastructure once a patient has been trained and supply logistics are established. Asia-Pacific is projected to expand at approximately 8.2% annually through 2035 as China, India, and Southeast Asian markets add kidney-care infrastructure. Domestic suppliers such as Huaren, CR Double-Crane, Qingshan Likang, and Bluesail strengthen regional manufacturing capacity, potentially improving availability of solutions and accessories.

Challenge

""Reliable daily supply and treatment continuity remain critical operational challenges.""

The central challenge is maintaining uninterrupted supply because peritoneal dialysis depends on frequent delivery of bulky sterile solution and disposable components. A patient using approximately 10 liters of dialysate daily can require around 300 liters per month. Across 10,000 patients, this represents approximately 3 million liters of monthly solution movement before accounting for packaging and backup inventory. Weather disruptions, transportation problems, manufacturing interruptions, or warehouse shortages can therefore affect treatment continuity quickly. Unlike durable equipment that may remain in service for several years, dialysate and disposable sets must be replenished continuously.

Another challenge is balancing technology sophistication with simplicity. Connected cyclers can offer remote monitoring, prescription updates, and data integration, but patients still require intuitive interfaces and reliable operation. A machine used every night must perform across more than 300 treatment sessions per year with minimal unplanned interruption. Manufacturers therefore need to optimize at least 6 attributes simultaneously: reliability, usability, connectivity, portability, alarm management, and supply compatibility. As digital capabilities increase, cybersecurity and data privacy also become important because treatment information is transmitted between the patient's home and clinical systems.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Peritoneal Dialysis Machine: Peritoneal Dialysis Machine is estimated to hold approximately 27% market share and includes automated cyclers used primarily for overnight therapy. Modern machines can perform multiple fluid exchanges during approximately 8-10 hours while the patient sleeps. Connected devices increasingly transmit treatment data to clinics and allow remote prescription updates. In 2025, more than 7.7 million treatments were digitally transmitted through one major home-dialysis platform, demonstrating the scale of connected-machine utilization. Machine demand is supported by growth in automated therapy and patient preference for minimizing daytime treatment interruptions.

Peritoneal Dialysis Solution: Peritoneal Dialysis Solution leads with approximately 61% market share because sterile dialysate is consumed during every treatment. Individual bags commonly contain approximately 1.5-5 liters depending on treatment regimen and system design, while total daily fluid volumes can exceed 8 liters for many adult patients. This recurring use creates high replacement frequency compared with durable machines. Manufacturers compete through manufacturing quality, glucose concentration options, bag design, supply reliability, and compatibility with manual or automated systems.

Others: Others account for approximately 12% market share and include additional components required to maintain safe home therapy. These items can include tubing systems, catheter-related accessories, extension sets, adapters, connectors, drainage products, and other disposable treatment components. Recent regulatory activity has included extension-set configurations ranging from approximately 6 inches to 18 inches, illustrating the variety required across different patient setups. Although individually smaller than dialysate demand, these components are essential to infection prevention and treatment continuity.

By Applications

Machine: Machine applications represent approximately 31% market share and are supported by increasing use of automated peritoneal dialysis. Cyclers reduce the need for multiple manual daytime exchanges by performing several exchanges automatically during sleep. Modern systems increasingly include cloud connectivity, remote prescription management, and treatment-data transmission. A machine used 365 nights annually can generate hundreds of treatment records per patient each year, making digital connectivity increasingly valuable for nephrology teams managing large home-treatment populations.

Supplies: Supplies dominate with approximately 69% market share because peritoneal dialysis requires continual replenishment of solution, tubing, connectors, transfer systems, drainage products, and other disposable components. A patient using 4 solution bags each day can consume more than 1,400 bags annually. This recurring requirement creates predictable demand and makes supply-chain reliability a major competitive factor. Supplies are expected to remain the largest Application through 2035 even as connected Machine adoption expands.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is estimated to lead the Peritoneal Dialysis Market with approximately 36% global share in 2026. The United States has one of the largest home-dialysis populations among developed markets, with approximately 15% of dialysis patients treated at home during 2025. Baxter, Renax, and Tj Tianan provide supplied-company representation associated with the U.S. market, while Fresenius also maintains extensive regional home-dialysis operations. Supplies account for approximately 67% of regional Application demand.

The region is projected to expand approximately 5.8-6.5% annually through 2035. Digital connectivity is a major differentiator, with millions of treatment sessions already transmitted remotely every year. Regulatory activity continues around catheter systems, connectors, and home-dialysis technologies. Home-based care policies, patient preference, and pressure on dialysis-center capacity will continue supporting automated peritoneal dialysis adoption.

Europe

Europe accounts for approximately 23% of global Peritoneal Dialysis Market demand. Fresenius and B. Braun provide supplied-company representation from Germany. Supplies account for approximately 68% of regional Application demand, while Machine contributes around 32%. Connected automated peritoneal dialysis systems are gaining adoption across several European countries as healthcare providers expand remote management capabilities.

The region is projected to grow approximately 5.5-6.5% annually through 2035. Digital home-dialysis platforms increasingly combine monitoring, prescription management, and supply ordering. Rollouts of connected peritoneal dialysis systems accelerated across European countries during 2024-2026. Europe also benefits from established nephrology infrastructure and strong home-care programs, although adoption rates continue to vary substantially between countries.

Asia-Pacific

Asia-Pacific is estimated to represent approximately 31% of global Peritoneal Dialysis Market demand and is projected to be the fastest-growing region at approximately 8.2% annually. China has significant supplied-company representation through Huaren, CR Double-Crane, Qingshan Likang, and Bluesail, while Terumo represents Japan. Peritoneal Dialysis Solution accounts for approximately 65% of regional Product Type demand because fluid consumption drives the majority of recurring treatment volume.

China, India, Southeast Asia, and other emerging markets face rapidly growing kidney-disease burdens and uneven access to in-center dialysis. Home therapy can reduce transportation requirements, making peritoneal dialysis attractive for geographically dispersed populations. Approximately half of global peritoneal dialysis patients have historically been concentrated in a small number of countries including China, illustrating the region's strategic importance. Domestic solution and disposable manufacturing is expected to improve availability through 2035.

Middle East & Africa

Middle East & Africa accounts for approximately 4% of global Peritoneal Dialysis Market demand. Availability remains uneven, with peritoneal dialysis historically available in a substantially smaller share of lower-resource African countries than in high-income regions. Supplies account for approximately 72% of regional Application demand because dialysate and disposable products are the primary recurring requirements.

The region is projected to expand approximately 6.5-7.5% annually through 2035 as kidney-care capacity increases in Gulf countries, South Africa, Egypt, and selected other markets. Peritoneal dialysis can offer an infrastructure advantage where establishing conventional centers is difficult. However, dependable sterile solution production, distribution, training, and infection control must improve for adoption to expand materially.

List of Top Peritoneal Dialysis Companies

• Baxter (U.S.)
• Fresenius (Germany)
• B. Braun (Germany)
• Terumo (Japan)
• Huaren (China)
• CR Double-Crane (China)
• Qingshan Likang (China)
• Tj Tianan (U.S.)
• Renax (U.S.)
• Medionics (Canada)
• Bluesail (China)

Top 2 Companies Market Share

Baxter: Baxter is estimated to represent approximately 27-31% of competitive presence among the supplied companies, supported by longstanding specialization in peritoneal dialysis machines, dialysate, disposable sets, and connected home-treatment systems. Supplies account for approximately 69% of overall market demand, aligning strongly with the company's recurring solution and consumable business. Its remote-management ecosystem has also contributed to broader clinical adoption of automated peritoneal dialysis by enabling treatment information to be reviewed without requiring daily clinic visits.

Fresenius: Fresenius is estimated to represent approximately 24-28% of competitive presence among the supplied companies, supported by home-dialysis machines, disposable systems, clinical infrastructure, and expanding digital platforms. During 2025, more than 7.7 million patient treatments were digitally transmitted through its connected home-dialysis ecosystem, and approximately 58,000 therapy prescription programs were delivered remotely. Its 2026 global digital-platform expansion strengthens integration across treatment monitoring, prescription management, and supply workflows.

Investment Analysis

Investment in the Peritoneal Dialysis Market is increasingly directed toward connected cyclers, remote monitoring, sterile-solution capacity, supply-chain automation, and patient-support infrastructure. Digital platforms can connect thousands of patients simultaneously while transmitting millions of treatment records each year. Investment in cloud-based systems reduces dependence on manual paper logs and gives clinicians access to structured treatment data. Manufacturers are also investing in remote prescription capabilities because therapy changes can sometimes be transmitted electronically instead of requiring reprogramming during an in-person visit. The delivery of approximately 58,000 remote prescription programs during 2025 demonstrates growing clinical acceptance of this model.

Manufacturing capacity for Supplies is another priority because recurring products represent approximately 69% of Application demand. A patient consuming 10 liters of solution daily requires around 3,650 liters annually, meaning 100,000 patients can create demand exceeding 365 million liters per year. This scale requires automated filling, sterile manufacturing, quality testing, warehousing, and transportation networks. Through 2035, investment is expected to concentrate across at least 6 areas: cycler connectivity, sterile fluid manufacturing, disposable systems, patient training, remote monitoring, and last-mile delivery.

New Product Development

New Product Development in the Peritoneal Dialysis Market is centered on easier-to-use automated cyclers, connected treatment management, safer disposable systems, and more efficient home logistics. Digital platforms introduced in 2026 increasingly integrate peritoneal dialysis monitoring with prescription management and supply ordering within one regulated environment. Connected systems can automatically transfer treatment information from the patient's home to the clinic, reducing manual data entry. Product development is also focused on quieter equipment, smaller footprints, touchscreen interfaces, portability, and simpler setup because patients may use a cycler for approximately 8-10 hours every night.

Disposable-system development remains equally important because infection prevention depends on secure connections and standardized fluid pathways. New catheter extension systems and adapters have been developed in multiple lengths ranging from approximately 4 inches to 18 inches to support different home-treatment configurations. Future products will increasingly compete across at least 7 characteristics: connection safety, ease of setup, portability, treatment automation, remote connectivity, alarm management, and supply efficiency. Peritoneal Dialysis Solution will remain the largest Product Type at approximately 61% share because therapy continues to require recurring high-volume dialysate consumption.

Five Recent Developments

• July 2026: Remote patient monitoring gained further clinical attention for peritoneal dialysis as digital home-care platforms expanded continuous treatment-data collection and earlier intervention capabilities.
• June 2026: Fresenius launched a unified global home-dialysis digital platform integrating remote therapy monitoring, remote prescription management, and supply ordering for peritoneal dialysis programs.
• April 2025: Fresenius received U.S. clearance for new peritoneal dialysis catheter extension sets and adapters covering configurations from approximately 4 inches to 18 inches.
• February 2025: Connected peritoneal dialysis programs continued scaling globally after digital systems transmitted more than 7.7 million treatment records and approximately 58,000 remote prescription programs during the year.
• May 2024: Remote therapy management expanded into additional European peritoneal dialysis programs covering both automated and manual treatment workflows, strengthening international adoption of connected home care.

Report Coverage

The Peritoneal Dialysis Market report covers the 2026-2035 forecast period using the stated 2025 baseline and evaluates the supplied Product Types of Peritoneal Dialysis Machine, Peritoneal Dialysis Solution and Others. Estimated Product Type shares are approximately 27%, 61%, and 12%, respectively. Application coverage includes Machine at approximately 31% and Supplies at 69%. The analysis examines automated peritoneal dialysis, home-based renal replacement therapy, remote patient monitoring, digital prescription management, sterile dialysate, connectors, catheter accessories, treatment-data transmission, supply logistics, infection prevention, patient training, and connected clinical workflows. Current industry indicators include approximately 4.5 million global dialysis patients, around 11% global peritoneal dialysis penetration, treatment sessions commonly lasting 8-10 hours for automated therapy, and recurring solution requirements that can exceed 8 liters per patient per day.

Regional coverage includes North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa, with estimated market shares of approximately 36%, 31%, 23%, 6%, and 4%, respectively. Competitive coverage includes all 11 supplied companies: Baxter, Fresenius, B. Braun, Terumo, Huaren, CR Double-Crane, Qingshan Likang, Tj Tianan, Renax, Medionics, and Bluesail. The report evaluates how kidney failure prevalence, home-dialysis adoption, automated cyclers, remote monitoring, digital care management, sterile-solution capacity, domestic manufacturing, patient education, and supply-chain reliability will influence market development through 2035. Supplies remain the commercial foundation at approximately 69% of Application demand, while digital Machine platforms are expected to become increasingly important for patient retention, clinical oversight, and long-term home-treatment expansion.